Mediti Pharma Overview

  • Founded
  • 2016
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Mediti Pharma General Information

Description

Developer of drugs designed to treat Alzheimer's disease. The company's drugs provide assistance to identify and cure early symptoms of the disease such as hallucinations, delusions and aggression, enabling healthcare providers to improve the lives of Alzheimer's disease patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 1255 Boule, Robert-Bourassa
  • Suite 1610
  • Montreal, Quebec H3B 3X3
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mediti Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 15-Apr-2021 Completed Out of Business
1. Early Stage VC 20-Jun-2016 Completed Startup
To view Mediti Pharma’s complete valuation and funding history, request access »